A Phase 4 interventional study of rHCG 250ug and uHCG 5000 IU in Infertility, sponsored by Eugonia. Status unknown at 1 site in Greece. Open to female participants aged 18 Years to 39 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-01-20.
Sponsored by Eugonia · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Infertility by Eugonia — none open to participants now, none under way, none of them phase 3. Infertility · Eugonia.
Among the 13 studies in Infertility by Eugonia, this one is the 3rd largest by enrollment of the 10 interventional ones that give a count, is the only one that started in 2013, is one of 5 in phase 4, and was the 1st registered.
2,090 studies on the registry are indexed under Infertility; 356 are open to participants now.
Browse Infertility studies →None of the 13 studies in Infertility by Eugonia is open now. The open studies under Infertility, anywhere →
Of the 233 Infertility studies recruiting now, 43 (18%) set no upper age limit and 184 (79%) stop at 75 or younger; 27 take children under 18; 74 take healthy volunteers.
This study: 18 Years to 39 Years · female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 1 started in 2013.
This study's enrollment of 150 is above the median of 134 across 1,415 interventional studies indexed under Infertility.
Median enrollment 84 across the 10 interventional studies, 60 across the 3 observational. Of the 7 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Eugonia is the lead sponsor of 16 studies on the registry; none are open to participants now.
None of the studies under way reaches primary completion within a year.
Among the 13 studies in Infertility by Eugonia, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to compare the clinical outcomes of recombinant human chorionic gonadotrophin (rHCG) and urinary HCG (uHCG) in patients undergoing IVF cycles.
Urinary human chorionic gonadotrophin (u-hCG) has been widely used to induce final oocyte maturation and to trigger ovulation in assisted conception. Recombinant technology has allowed the production of r-hCG inj which all urinary contaminants are absent. Hence, this would allow the safe subcutaneous administration of a compound with less batch-to-batch variation. This study will investigate the effectiveness of the recombinant hCG compared to the currently used urinary hCG.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Injection of 250 ug Ovitrelle to trigger final oocyte maturation
Drug: rHCG 250ug
Injection of 5000 IU Pregnyl to trigger final oocyte maturation
Drug: uHCG 5000 IU
Injection of 7500 IU Pregnyl to trigger final oocyte maturation
Drug: uHCG 7500 IU
Injection of 250 ug Ovitrelle to trigger final oocyte maturation
Also known as: Ovitrelle
Injection of 5000 IU Pregnyl to trigger final oocyte maturation
Also known as: Pregnyl 5000 IU
Injection of 7500 IU Pregnyl to trigger final oocyte maturation
Also known as: Pregnyl 7500 IU
Percentage of mature oocytes
Percentage MII/COCs
Time frame: Day of oocyte retrieval (Day 0)
Positive test per embryo transfer
Time frame: 15 days post oocyte retrieval
Clinical pregnancy per embryo transfer
Time frame: 7 weeks of gestation
Ongoing pregnancy per embryo transfer
Time frame: 12 weeks of gestation
Level of serum hCG on day of oocyte retrieval
Time frame: Day of oocyte retrieval
Number of oocytes (COC) retrieved
Time frame: Day of oocyte retrieval
Number of mature oocytes (MII)
Time frame: Day of oocyte retrieval
Oocyte retrieval rate
Number of oocytes retrieved/number of follicles on the day of triggering final oocyte maturation
Time frame: Day of oocyte retrieval (Day 0)
Incidence of severe early OHSS
Time frame: up to Day 5 post oocyte retrieval
The record gives a start of Jun 2013, a primary completion of Dec 2015 and a completion of Jul 2016. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Jan 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Ovidrel
Eugonia